GOVERNANCE

Our commitment to corporate governance is based on ethics and integrity.

Corporate Social Responsibility

Corporate Social Responsibility

Overview

  • Overview
  • Gender Policy
  • Archive
  • Corporate Social Responsibility (CSR)

    At Genmab, we believe our actions should benefit our stakeholders and society, as a whole. With our core values and core purpose, being socially responsible is fundamental to the way we do business. We are committed to building a sustainable organization that meets environment, social and governance (ESG) criteria that are relevant to our business operations.

    Our Corporate Social Responsibility (CSR) Committee, chaired by our CEO, is comprised of representatives from our human resources, investor relations and communications, legal, compliance, finance, and research and development functions. The committee ensures CSR activities are carried out effectively at Genmab and results are communicated clearly and openly. Our CSR and ESG strategy is focused on:

    • Employee well-being: We believe that an engaged, inclusive and diverse workforce attracts top talent to drive passion and innovation. Caring for employees’ health, safety and overall well-being is a key component of our culture and critical to our company’s success.
    • Ethics and compliance: In relation to pre-clinical and clinical studies, we comply with international regulations and standards for drug development and all relevant guidelines issued by international regulatory authorities such as the European Medicines Agency (EMA), the U.S. Food and Drug Administration (FDA) and others.
    • Environment: We focus on environmental protection in our daily activities and decision making by encouraging employees to act in an environmentally friendly way including minimizing energy consumption, minimizing CO2 footprint, waste management and recycling.
    • Business ethics and transparency: Genmab adheres to its Code of Business Conduct and Ethics which sets high ethical standards for all our employees and the Board of Directors when conducting business on behalf of Genmab. We have optimized our governance around different compliance areas by establishing various steering committees and governance boards.

    To learn more, download our CSR report, 2019

  • Gender Policy

    Policy regarding the Diversity and Proportion of Gender in other Management Levels of the Genmab group:

    This policy has been adopted by the Board of Directors of Genmab A/S ("Genmab") in accordance with Section 139a of the Danish Companies Act and the Danish Recommendations on Corporate Governance.

    Genmab recognizes the importance of promoting diversity and is committed to continue working towards and maintaining diversity and equal opportunities for employees at all management levels in the Genmab group, regardless of gender, age, race, religion or ethnicity. Genmab encourages talented employees to pursue a career in the company. Genmab regularly conducts employee surveys and employee development interviews to identify barriers – or the perception of barriers – preventing equal opportunities for employees. In connection with recruitment, including recruitment at management level, it is the policy of the Genmab group to meet the company's needs for employees with the right skills and competences, regardless of gender, age, race, religion or ethnicity. When choosing between equally qualified candidates, the diversity among the employees shall be taken into consideration, as it is the aim that both genders attain a representation at management levels of at least 40%. In connection with recruitment for managerial positions it must be ensured that the employment procedures are designed to give men and women equal opportunities to apply for and obtain managerial positions and, where possible, that the candidates invited for interview include both men and women. The company's focus on diversity among its employees, including at management levels, must be visible during recruitment.

    The policy may be amended by the Board of Directors and should be interpreted in accordance with applicable equal rights and anti-discrimination legislation in Denmark, in force from time to time.

    A Target Figure for the Number of Women in the Board of Directors of Genmab A/S has been established.  Click here for more information.

  • CSR Report Archive
    CSR Report 2019 - English Download
    CSR Report 2018 - English Download
    CSR Report 2017 - English Download
    CSR Report 2016 - English Download
    CSR Report 2015 - English Download
    CSR Report 2014 - English Download
    CSR Report 2013 - Danish Download
    CSR Report 2013 - English Download
    CSR Report 2012 - English Download
    CSR Report 2012 - Danish Download
    CSR Report 2011 - English Download
    CSR Report 2011 - Danish Download

You are now leaving Genmab.com to go to our collaborator’s website. If you continue, we encourage you to read the website’s privacy and cookie policy.